In a televised address on Saturday, Prime Minister Narendra Modi has announced that the vaccination against Covid-19 for children between 15-18 years will begin from January 3, 2022.
The latest study conducted by the Indian Council of Medical Research (ICMR) has revealed which vaccine provides more protection against the Delta Plus variant of the pandemic.
Covishield is manufactured by the Serum Institute of India in Pune while Covaxin is manufactured by the Hyderabad-based Bharat Biotech in collaboration with ICMR and the National Institute of Virology.
As the nation nears the third phase of the vaccination, this TNS guide brings you on how you can register for the third phase of the vaccination if you fall under the 18-44 age category.
The sudden announcement of increasing the price has sparked outrage across the country as the increase has come at a high time when the nation is at peak of the COVID-19 cases.
